A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427

Parasites and Vectors

Volumn 2, Issue 1, 2009, Pages

  Sykes, Melissa L ^a   Avery, Vicky M ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIMINAZENE; EFLORNITHINE; LUCIFERASE; MELARSOPROL; PENTAMIDINE; STAUROSPORINE; SURAMIN;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; IC 50; NONHUMAN; PARASITE IDENTIFICATION; PROTEIN ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA BRUCEI;

TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMA BRUCEI RHODESIENSE;

EID: 72949114340     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-2-54     Document Type: Article

References (35)

1. Human African trypanosomiasis (sleeping sickness): epidemiological update. Wkly Epidemiol Rec 2006 81 71 80
2. The treatment of human African trypanosomiasis. J Pepin F Milord, Adv Parasitol 1994 33 1 47 8122565 (Pubitemid 23357084)
3. Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya. JD Bales Jr SM Harrison DL Mbwabi PJ Schecter, Ann Trop Med Parasitol 1989 83 Suppl 1 111 114 2515816
4. Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment. C Burri J Keiser, Trop Med Int Health 2001 6 412 420 11348536
5. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. E Matovu ML Stewart F Geiser R Brun P Maser LJ Wallace RJ Burchmore JC Enyaru MP Barrett R Kaminsky T Seebeck HP de Koning, Eukaryot Cell 2003 2 1003 1008 14555482
6. Combination of eflornithine and melarsoprol for melarsoprol-resistant Gambian trypanosomiasis. B Mpia J Pepin, Trop Med Int Health 2002 7 775 779 12225509
7. Opportunities and challenges in antiparasitic drug discovery. R Pink A Hudson MA Mouries M Bendig, Nat Rev Drug Discov 2005 4 727 740 16138106
8. New drugs for neglected diseases: from pipeline to patients. B Pecoul, PLoS Med 2004 1 6 15526054
9. Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity. GA Holloway WN Charman AH Fairlamb R Brun M Kaiser E Kostewicz PM Novello JP Parisot J Richardson IP Street KG Watson JB Baell, Antimicrob Agents Chemother 2009 53 2824 2833 19364854
10. High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity. DC Martyn DC Jones AH Fairlamb J Clardy, Bioorg Med Chem Lett 2007 17 1280 1283 17197182
11. Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance. CA Lanteri ML Stewart JM Brock VP Alibu SR Meshnick RR Tidwell MP Barrett, Mol Pharmacol 2006 70 1585 1592 16912218
12. In vitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolense by iron chelators. K Merschjohann D Steverding, Kinetoplastid Biol Dis 2006 5 3 16914038
13. Interaction of monobenzamidine-linked trypanocides with the Trypanosoma brucei P2 aminopurine transporter. ML Stewart C Boussard R Brun IH Gilbert MP Barrett, Antimicrob Agents Chemother 2005 49 5169 5171 16304196
14. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b.rhodesiense and T.b.gambiense) in vitro. B Raz M Iten Y Grether-Buhler R Kaminsky R Brun, Acta Trop 1997 68 139 147 9386789
15. Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427. ML Sykes VM Avery, Am J Trop Med Hyg 2009 81 665 674 19815884
16. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei. ZB Mackey AM Baca JP Mallari B Apsel A Shelat EJ Hansell PK Chiang B Wolff KR Guy J Williams JH McKerrow, Chem Biol Drug Des 2006 67 355 363 16784460
17. A cathepsin B-like protease is required for host protein degradation in Trypanosoma brucei. ZB Mackey TC O'Brien DC Greenbaum RB Blank JH McKerrow, J Biol Chem 2004 279 48426 48433 15326171
18. Pharmacology of existing drugs for animal trypanosomiasis. LD Kinabo, Acta Trop 1993 54 169 183 7902656
19. Identification of the trypanocidal factor in normal human serum: high density lipoprotein. MR Rifkin, Proc Natl Acad Sci USA 1978 75 3450 3454 210461
20. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. JH Zhang TD Chung KR Oldenburg, J Biomol Screen 1999 4 67 73 10838414
21. A comparison of assay performance measures in screening assays: signal window, Z' factor, and assay variability ratio. PW Iversen BJ Eastwood GS Sittampalam KL Cox, J Biomol Screen 2006 11 247 252 16490779
22. Development of a high-throughput fluorescence polarization assay for Bcl-x(L). H Zhang P Nimmer SH Rosenberg SC Ng M Joseph, Anal Biochem 2002 307 70 75 12137781
23. Alternative statistical parameter for high-throughput screening assay quality assessment. Y Sui Z Wu, J Biomol Screen 2007 12 229 234 17218666
24. Effects of protein kinase and phosphatidylinositol-3 kinase inhibitors on growth and ultrastructure of Trypanosoma cruzi. MV Braga W de Souza, FEMS Microbiol Lett 2006 256 209 216 16499608
25. On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. D Arnoult K Akarid A Grodet PX Petit J Estaquier JC Ameisen, Cell Death Differ 2002 9 65 81 11803375
26. Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. H Hirumi K Hirumi, J Parasitol 1989 75 985 989 2614608
27. In vitro assays to determine drug sensitivities of African trypanosomes: a review. R Kaminsky R Brun, Acta Trop 1993 54 279 289 7902665
28. Activity of a trypanosome metacyclic variant surface glycoprotein gene promoter is dependent upon life cycle stage and chromosomal context. SV Graham B Wymer JD Barry, Mol Cell Biol 1998 18 1137 1146 9488428
29. Kinetic analysis of growth rate, ATP, and pigmentation suggests an energy-spilling function for the pigment prodigiosin of Serratia marcescens. PL Haddix S Jones P Patel S Burnham K Knights JN Powell A LaForm, J Bacteriol 2008 190 7453 7463 18805986
30. Cell density-dependent regulation of ATP levels during the growth cycle of cultured Chinese hamster ovary cells. M Fiorani O Cantoni G Piccoli B Biagiarelli V Stocchi, Biochem Mol Biol Int 1994 32 251 258 8019430
31. Analysis of mammalian viable cell biomass based on cellular ATP. SA Sonderhoff DG Kilburn JM Piret, Biotechnol Bioeng 1992 39 859 864 18601019
32. Membrane changes and adenosine triphosphate content in normal and malignant transformed cells. I Vlodavsky M Inbar L Sachs, Proc Natl Acad Sci USA 1973 70 1780 1784 4352654
33. Differentiation of African trypanosomes is controlled by a density sensing mechanism which signals cell cycle arrest via the cAMP pathway. E Vassella B Reuner B Yutzy M Boshart, J Cell Sci 1997 110 Pt 21 2661 2671 9427384
34. Serum-free hybridoma culture: ethical, scientific and safety considerations. MS Even CB Sandusky ND Barnard, Trends Biotechnol 2006 24 105 108 16427150
35. Serum albumin binding at cytotoxic concentrations of chemicals as determined with a cell proliferation assay. M Gulden S Morchel H Seibert, Toxicol Lett 2003 137 159 168 12523958